Healthcare Professionals

Why Zensor™ device

Zensor™ device is the world’s first three lead, 14 days continuous ECG and remote event device available on the market. This small yet powerful system enables the transmission of comprehensive ECG data to allow you diagnose patient arrhythmias including Atrial Fibrillation. Cleared for use by the US FDA and CE marked, the Zensor™ device is a wi-fi enabled patient monitor that captures the electrical rhythm and the rate of your patient’s heart for up to 14 days.



  • 3 lead wi-fi enabled ECG monitoring system
  • Up to 14 day continuous beat by beat data capture and recording
  • Event transmission and near real time recording in one device
  • High quality data capture through use of proprietary motion artefact reducing electrodes
  • Patient activated event recording feature
  • Wi-fi enabled for data transmission

The Zensor™

Device Allows for

  • Diagnosis of five cardiac arrhythmias including Atrial Fibrillation
  • Remote monitoring of your patients
  • Recording and transmission of an ECG by a patient
  • Full generation of a report with up to 14 days of patient cardiac data
  • Easy patient use - small, lightweight, unobtrusive device

Compliance and Feedback

The patient friendly Zensor™ device facilitates high patient compliance. With minimal set up and maintenance required by the patient, all the data you need will be collected and collated for you over a single monitoring period.
Clinician and patient feedback for the Zensor™ device has been overwhelmingly positive – here is a just selection of the positive feedback we have received from both clinicians and patients.


Health professional and end user feedback


  • "Very useful for quick diagnosis"
  • "Patients have been positive about the experience"
  • "State of the art device, which is compact and easy to wear for the patients"
  • "Easy to use for clinical staff and patients"


  • "A very positive and quick way to be diagnosed"
  • "After a dry or two I did not notice wearing it"
  • "I felt confident using the Zensor™ device"
  • "The device was fine to wear, forgot it was on most of the time"
  • "It is a good idea to have a device which you can use in real time"

Clinician and patient feedback disclosed in this booklet was captured as part of a Zensor™ device evaluation at South Eastern Health and Social Care Trust, Northern Ireland and a Stroke Prevention study.

Add Zensor™ device

to Your Practice

The Zensor™ device is a complete system solution to allow you to measure and record a patient’s heart rhythm for up 14 days. As well as continually capturing and recording beat by beat data for your patient, this unique device can, should you choose, capture patient activated events on a daily basis. By recording a patient’s heart rhythm continuously for up to 14 days, as well as capturing daily events, you may be able to make quick clinical decisions, reduce number of tests you need to undertake and quickly put your patient on an effective treatment pathway.

4 Simple Steps

for quicker diagnosis

Step 1

Zensor™ device assigned, placed on patient and activated

Step 2

Data transmits to Zensor™ device monitoring centre where data is captured

Step 3

After 14 days (or earlier if Clinician chooses) patient returns device to Clinician for processing in device monitoring centre

Step 4

Report sent back to Clinician to support diagnosis

Device Specifications

The Zensor™device sets a new standard for cardiac monitoring with extended ambulatory monitoring together with event capture in near real time for a comprehensive and timely read out of your patient’s cardiac data.


For detail on the device specifications, please click button below.


and Support

To have the best possible experience with your Zensor™ device, we will support you every step of the way. Our dedicated team of clinical experts and customer support staff are there to help you incorporate the Zensor™ device into your practice so that you can diagnose your at-risk patients as quickly as possible

Here are some of the support materials developed for you

If you require any more specific information for you or your patients, please contact us at T: +353 90 646 5499

Clinical Evidence

Supporting Zensor™ device

The Zensor™ device has been used to date in hundreds of patients in Europe and the US. At Tallaght University Hospital, Dublin, Ireland, a study was undertaken to identify high risk patients with AF. The device was proven to deliver a convenient and reliable method of diagnosing AF in a high risk population.